The report sits on the table, and the words "non-small cell lung cancer" are circled. Your oncologist has mentioned immunotherapy

Your chemotherapy stopped working. The scans show new growth, and your oncologist is recalibrating the plan.

You have just received an esophageal cancer diagnosis, and the term "immunotherapy" keeps surfacing in your frantic late-night research.

A family member has just been diagnosed with advanced non-small cell lung cancer (NSCLC). The first wave of shock is quickly followed by paralyzing confusion

Your oncologist has just recommended a chemotherapy regimen with a staggering six-figure price tag.